Related references
Note: Only part of the references are listed.Effects of β-Naphthoflavone on Ugt1a6 and Ugt1a7 Expression in Rat Brain
Yukiko Sakakibara et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Effects of Phenobarbital on Expression of UDP-Glucuronosyltransferase 1a6 and 1a7 in Rat Brain
Yukiko Sakakibara et al.
DRUG METABOLISM AND DISPOSITION (2016)
The role of the dorsal noradrenergic pathway of the brain (locus coeruleus) in the regulation of liver cytochrome P450 activity
Marta Kot et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Expression of UDP-Glucuronosyltransferase 1 (UGT1) and Glucuronidation Activity toward Endogenous Substances in Humanized UGT1 Mouse Brain
Yuki Kutsuno et al.
DRUG METABOLISM AND DISPOSITION (2015)
QUANTITATIVE EXPRESSION PROFILING IN MOUSE SPINAL CORD REVEALS CHANGING RELATIONSHIPS AMONG CHANNEL AND RECEPTOR MRNA LEVELS ACROSS POSTNATAL MATURATION
V. B. Garcia et al.
NEUROSCIENCE (2014)
Comparison of Serotonin Glucuronidation Activity of UDP-glucuronosyltransferase 1a6a (Ugt1a6a) and Ugt1a6b: Evidence for the Preferential Expression of Ugt1a6a in the Mouse Brain
Shinsuke Uchihashi et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
Determination of Serotonin and Dopamine Metabolites in Human Brain Microdialysis and Cerebrospinal Fluid Samples by UPLC-MS/MS: Discovery of Intact Glucuronide and Sulfate Conjugates
Tina Suominen et al.
PLOS ONE (2013)
Quantification of Human Uridine-Diphosphate Glucuronosyl Transferase 1A Isoforms in Liver, Intestine, and Kidney Using Nanobore Liquid Chromatography-Tandem Mass Spectrometry
David E. Harbourt et al.
ANALYTICAL CHEMISTRY (2012)
Simultaneous Absolute Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases as a Novel Approach for the Characterization of Individual Human Liver: Comparison with mRNA Levels and Activities
Sumio Ohtsuki et al.
DRUG METABOLISM AND DISPOSITION (2012)
Analysis of Intact Glucuronides and Sulfates of Serotonin, Dopamine, and Their Phase I Metabolites in Rat Brain Microdialysates by Liquid Chromatography-Tandem Mass Spectrometry
Paivi Uutela et al.
ANALYTICAL CHEMISTRY (2009)
Dopamine Is a Low-Affinity and High-Specificity Substrate for the Human UDP-Glucuronosyltransferase 1A10
Katriina Itaaho et al.
DRUG METABOLISM AND DISPOSITION (2009)
Quantitative Analysis of UDP-Glucuronosyltransferase (UGT) 1A and UGT2B Expression Levels in Human Livers
Takeshi Izukawa et al.
DRUG METABOLISM AND DISPOSITION (2009)
Species differences in UDP-Glucuronosyltransferase activities in mice and rats
Hirotada Shiratani et al.
DRUG METABOLISM AND DISPOSITION (2008)
Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties
Shuji Ohno et al.
DRUG METABOLISM AND DISPOSITION (2008)
Real-time PCR determination of rRNA gene copy number:: absolute and relative quantification assays with Escherichia coli
Changsoo Lee et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2008)
Induction of rat UDP-glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways
M. K. Shelby et al.
DRUG METABOLISM AND DISPOSITION (2006)
Absolute and relative QPCR quantification of plasmid copy number in Escherichia coli
Changsoo Lee et al.
JOURNAL OF BIOTECHNOLOGY (2006)
Activity and expression of various isoforms of uridine diphosphate glucuronosyltransferase are differentially regulated during hepatic regeneration in rats
H Tian et al.
PHARMACEUTICAL RESEARCH (2005)
An investigation of human and rat liver microsomal mycophenolic acid glucuronidation: Evidence for a principal role of UGT1A enzymes and species differences in UGT1A specificity
KK Miles et al.
DRUG METABOLISM AND DISPOSITION (2005)
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily
PI Mackenzie et al.
PHARMACOGENETICS AND GENOMICS (2005)
Kinetic characterization of the 1A subfamily of recombinant human UDP-glucuronosyltransferases
L Luukkanen et al.
DRUG METABOLISM AND DISPOSITION (2005)
Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism
N Picard et al.
DRUG METABOLISM AND DISPOSITION (2005)
The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases
BT Ethell et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family
MK Shelby et al.
DRUG METABOLISM AND DISPOSITION (2003)
Glucuronidation enzymes, genes and psychiatry
J de Leon
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2003)
Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6
S Krishnaswamy et al.
DRUG METABOLISM AND DISPOSITION (2003)
Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38)
JF Gagné et al.
MOLECULAR PHARMACOLOGY (2002)
Share Paper
